EMEA-000627-PIP01-09-M04
Key facts
| Invented name |
Corlentor
|
| Active substance |
ivabradine hydrochloride
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0101/2013
|
| PIP number |
EMEA-000627-PIP01-09-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
|
| Contact for public enquiries |
Les Laboratoires Servier
|
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000627-PIP01-09-M04
|
| Compliance opinion date |
10/10/2014
|
| Compliance outcome |
positive
|